Kush Gulati

Kush Gulati is a qualified professional with experience in strategy analysis and venture capital, particularly within the healthcare sector. At Accenture, Kush served as a Senior Strategy Analyst and previously as a Strategy Analyst from May 2024 to May 2025. Prior experience includes an Analyst Intern position at Touchdown Ventures from December 2022 to December 2023, where Kush focused on healthcare corporate venture capital, and participation in the Touchdown Ventures College Program as a Venture Capital Intern. Additional experience includes a Strategy Insights & Planning Associate Intern role at ZS, gaining expertise in pharmaceuticals, oncology, and rare diseases between June 2022 and August 2022, and a Product Development Intern position at Bristol Myers Squibb, where tasks involved exploring AI applications in pharmaceutical formulation during the summer of 2021. Kush holds a Bachelor of Science in Engineering in Biomedical Engineering from Duke University, completed in May 2023.